RandallPellishMD

Inflammatory Bowel Disease

Director, Lahey Inflammatory Bowel Disease Center. Assistant Professor of Medicine, Tufts University Medical School

Dr. Pellish is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Lahey Hospital & Medical Center
41 Burlington Mall Rd
Burlington, MA 01805
Phone+1 781-744-8740

Dr. Randall Pellish is a gastroenterologist at the Lahey Hospital and Medical Center in Burlington, MA where is the director of the Inflammatory Bowel Disease Center. He received his medical degree from UMass Chan Medical School and has been in practice 16 years. He specializes in inflammatory bowel disease (Crohn's and ulcerative colitis) and is highly experienced in general gastroenterology, gastrointestinal bleeding, and endoscopy.

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 4
Roles: Principal Investigator
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet Start of enrollment: 2022 Jun 30
Active, not recruiting
Phase 2
Roles: Principal Investigator

PubMed

105 citations
Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope study group.
Daniel C. DeMarco, Elizabeth Odstrcil, Luis F. Lara, David R. Bass, Chase R. Herdman
Gastrointestinal Endoscopy. 2010-03-01
29 citations
Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study.
Barbara Olendzki, Vanni Bucci, Caitlin Cawley, Rene Maserati, Margaret McManus
Gut Microbes. 2022-03-21
10 citations
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation.
Shahrad Hakimian, Yevgeniy Popov, Abbas Rupawala, Karen Salomon-Escoto, Steven Hatch
Biologics. 2018-02-27

AI Being Used to Perform Molecular Analysis of Biopsies from Bowel Disease PatientsJuly 12th, 2022
IBD Center Aims to Help Patients with Crohn’s and ColitisNovember 4th, 2019
The Difference Between a Gluten Sensitivity and Celiac DiseaseOctober 1st, 2019